home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Menu
home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Archives:
from-the-press
PainReform raised $ 20 million in initial public offering on NASDAQ
$ 15 million and final stage in painkiller trial in Painreform
